|
American Society of Clinical Oncology has issued what it calls a "provisional clinical opinion" on prostate-specific antigen screening for prostate cancer that is at odds with guidelines issued in May by the U.S. Preventive Services Task Force.ASCO recommends against screening men with a life expectancy of 10 years or less "because harms seem to outweigh potential benefits." For those with a life ...
|
